Viewing Study NCT06929169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-05-19 @ 1:48 PM
Study NCT ID: NCT06929169
Status: RECRUITING
Last Update Posted: 2025-04-16
First Post: 2025-04-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
Sponsor: Maximo Agustin Schiavone
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease Requiring Hemodialysis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SGLT2 Inhibitors View
None Hemodialysis View
None Cardiac MRI View
None Ventricular Remodeling View
None Heart Failure with Preserved Ejection Fraction View
None Myocardial Fibrosis View
None Cardiovascular Disease View
None Chronic Kidney Disease View